NIP
ALXO icon

Nicholas Investment Partners’s ALX Oncology ALXO Stock Holding History

Nicholas Investment Partners’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47,872
Closed -$3.54M – 196
2021
Q3 		$3.54M Sell
47,872
-11,918
-20% -$794K 0.26% 126
2021
Q2 		$3.27M Buy
59,790
+16,058
+37% +$961K 0.21% 130
2021
Q1 		$3.23M Sell
43,732
-300
-0.7% -$23.6K 0.22% 117
2020
Q4 		$3.8M Buy
+44,032
New +$2.65M 0.29% 102

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Nicholas Investment Partners's ALXO Position: Q4 2021 in Review

Nicholas Investment Partners sold out of ALX Oncology (ALXO) in Q4 2021, closing a stake of 47,872 shares — an estimated $3.54M sold.

Nicholas Investment Partners first reported a position in ALXO in Q4 2020 and held it in 4 quarters. The position peaked at $3.8M in Q4 2020. 108 funds tracked by Wall St. Rank hold ALXO as of Q4 2021.

  • Nicholas Investment Partners reported no remaining ALX Oncology position as of Q4 2021 after selling out during the quarter.
  • Nicholas Investment Partners sold 47,872 ALX Oncology shares in Q4 2021, an estimated $3.54M.
  • Nicholas Investment Partners first reported a position in ALX Oncology in Q4 2020 and held it in 4 quarters.
  • Nicholas Investment Partners's ALX Oncology position peaked at $3.8M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2021.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.